Browse Title Index


 
Issue Title
 
Vol 24, No 2 (2017) Metformin and breast cancer stage at diagnosis: a population-based study Abstract   PDF   HTML
I.C. Lega, K. Fung, P.C. Austin, L.L. Lipscombe
 
Vol 23, No 3 (2016) Metronomic Chemotherapy and Palliative Radiotherapy as Salvage Treatment of Refractory or Relapsed Pediatric Solid Tumors Abstract   PDF   HTML
A.M. Ali, M.I. El-Sayed
 
Vol 23, No 3 (2016) Metronomic chemotherapy with 5-fluorouracil and cisplatin for inoperable malignant bowel obstruction because of peritoneal dissemination from gastric cancer Abstract   PDF   HTML
S. Yang, S. Li, H. Yu, S. Li, W. Liu, X. Liu, H. Ma
 
Vol 16, No 2 (2009) METRONOMIC CHEMOTHERAPY: CHANGING THE PARADIGM THAT MORE IS BETTER Abstract   PDF
O.Graciela Scharovsky, Leandro E. Mainetti, Viviana R. Rozados
 
Vol 16, No 4 (2009) Microbes and Colorectal Cancer: Is There a Relationship? Abstract   PDF
Christian Jobin, Joshua M Uronis
 
Vol 23, No 2 (2016) MicroRNA expression profiling of sputum for the detection of early and locally advanced non-small-cell lung cancer: a prospective case–control study Abstract   PDF   HTML
R. Razzak, E.L.R. Bédard, J.O. Kim, S. Gazala, L. Guo, S. Ghosh, A. Joy, T. Nijjar, E. Wong, W.H. Roa
 
Vol 17, No 1 (2010) MicroRNA let-7: an emerging next-generation cancer therapeutic Abstract   PDF
D. Barh, R. Malhotra, B. Ravi, P. Sindhurani
 
Vol 16, No 3 (2009) Might positron emission tomography actually treat micrometastatic cancer? Abstract   PDF
Mark R Goldstein, Luca Mascitelli, Francesca Pezzetta
 
Vol 19, No 5 (2012) Mindfulness-based stress reduction for breast cancer— a systematic review and meta-analysis Abstract   PDF   HTML
H. Cramer, R. Lauche, A. Paul, G. Dobos
 
Vol 14, No 6 (2007) Minds That Matter: 2007 Gairdner International Awards Lectures Details   PDF
Flora Krasnoshtein, Nikolai Nikolov
 
Vol 18, No 6 (2011) Mixing drinks and concocting troubles Abstract   PDF   HTML
L. Z. G. Touyz
 
Vol 18 (2011): The Optimization of Hormonal Therapy in Early Breast Cancer Models of care for early-stage breast cancer in Canada Abstract   PDF   HTML
Y. Madarnas, A. A. Joy, S. Verma, S. Sehdev, W. Lam, L. Sideris
 
Vol 19, No 3 (2012) Moderators of psychological recovery from benign cancer screening results Abstract   PDF   HTML
M. Pelletier, B. Knäuper, C. G. Loiselle, R. Perreault, C. Mizrahi, L. Dubé
 
Vol 24, No 3 (2017) Molecular progression in unusual recurrent non-pediatric intracranial clear cell meningioma Abstract   PDF   HTML
B. Domingo-Arrué, R. Gil-Benso, J. Megías, L. Navarro, T. San-Miguel, L. Muñoz-Hidalgo, C. López-Ginés, M. Cerdá-Nicolás
 
Vol 18, No 2 (2011) Monitoring response and resistance to treatment in chronic myeloid leukemia Abstract   PDF   HTML
S. Assouline, J. H. Lipton
 
Vol 15, No 1 (2008) Moses Judah Folkman 1933–2008 Details   PDF
Phil Gold
 
Vol 24, No 1 (2017) Moving guidelines into action: a report from Cancer Care Ontario’s event Let’s Get Moving: Exercise and Rehabilitation for Cancer Patients Abstract   PDF   HTML
J. Tomasone, C. Zwaal, G.M. Kim, D. Yuen, J. Sussman, R. Segal, on behalf of the Psychosocial Oncology and Survivorship Programs at Cancer Care Ontario
 
Vol 16 (2009): Renal Cell Carcinoma Supplement mTOR Inhibition in Kidney Cancer Abstract   PDF
Anil Kapoor
 
Vol 20, No 1 (2013) Multidisciplinary assessment of fitness to drive in brain tumour patients in southwestern Ontario: a grey matter Abstract   PDF   HTML
E. Chan, A.V. Louie, M. Hanna, G.S. Bauman, B.J. Fisher, D.A. Palma, G.B. Rodrigues, A. Sathya, D.P. D'Souza
 
Vol 18, No 5 (2011) Multidisciplinary Canadian consensus recommendations for the management and treatment of hepatocellular carcinoma Abstract   PDF   HTML
M. Sherman, K. Burak, J. Maroun, P. Metrakos, J. J. Knox, R. P. Myers, M. Guindi, G. Porter, J. R. Kachura, P. Rasuli, S. Gill, P. Ghali, P. Chaudhury, J. Siddiqui, D. Valenti, A. Weiss, R. Wong
 
Vol 19, No 4 (2012) Multidisciplinary management of cancer patients: chasing a shadow or real value? An overview of the literature Abstract   PDF   HTML
J. M. Croke, S. El-Sayed
 
Vol 24, No 3 (2017) Multidisciplinary retroperitoneal and pelvic soft-tissue sarcoma case conferences: the added value that radiologists can provide Abstract   PDF   HTML
R.S. Lim, A.Z. Kielar, R.H. El-Maraghi, M.A. Fraser, C. Nessim, S. Thipphavong
 
Vol 24, No 2 (2017) Multigene expression profile testing in breast cancer: is there a role for family physicians? Abstract   PDF   HTML
M.A. O'Brien, J.C. Carroll, D.P. Manca, B. Miedema, P.A. Groome, T. Makuwaza, J. Easley, N. Sopcak, L. Jiang, K. Decker, M.L. McBride, R. Moineddin, J.A. Permaul, R. Heisey, E.A. Eisenhauer, M.K. Krzyzanowska, S. Pruthi, C. Sawka, N. Schneider, J. Sussman, R. Urquhart, C. Versaevel, E. Grunfeld, for the Canadian Team to Improve Community-Based Cancer Care Along the Continuum
 
Vol 17 (2010): Managing Prostate Cancer in 2010 and Beyond: A Canadian Perspective Multimodal approaches to high-risk prostate cancer Abstract   PDF
A. Koupparis, M.E. Gleave
 
Vol 20, No 6 (2013) Multimodal cancer care research Abstract   PDF   HTML
N. MacDonald
 
Vol 17, No 3 (2010) Multimodality breast cancer screening in women with a familial or genetic predisposition Abstract   PDF
I. Trop, L. Lalonde, M.H. Mayrand, J. David, N. Larouche, D. Provencher
 
Vol 24, No 1 (2017) Nasopharyngeal non-intestinal-type adenocarcinoma: a case report and updated review of the literature Abstract   PDF   HTML
C. Jain, L. Caulley, K.I. Macdonald, B. Purgina, C.K. Lai, B. Esche, S. Johnson-Obaseki
 
Vol 13, No 1 (2006) Natural Health Products that Inhibit Angiogenesis: Part 1 Details   PDF
Stephen Mark Sagar, Donald Yance
 
Vol 13, No 3 (2006) Natural health products that inhibit angiogenesis: a potential source for investigational new agents to treat cancer?Part 2 Details   PDF
Stephen Sagar
 
Vol 16 (2009): Renal Cell Carcinoma Supplement Natural History and Management of Small Renal Masses Abstract   PDF
Simon Tanguay, Tamer Abou Youssif
 
Vol 21, No 6 (2014) Need to minimize bias when surveying patient attitudes to stopping cml treatment Abstract   PDF   HTML
L.A. Villemagne, D.M. Ross, P. Schofield
 
Vol 23, No 4 (2016) Negative predictive value of preoperative computed tomography in determining pathologic local invasion, nodal disease, and abdominal metastases in gastric cancer Abstract   PDF   HTML
D.J. Kagedan, F. Frankul, A. El-Sedfy, C. McGregor, M. Elmi, B. Zagorski, M.E. Dixon, A.L. Mahar, J. Vasilevska-Ristovska, L. Helyer, C. Rowsell, C.J. Swallow, C.H. Law, N.G. Coburn
 
Vol 21, No 1 (2014) Neoadjuvant endocrine treatment for breast cancer: from bedside to bench and back again? Abstract   PDF   HTML
R.R. Saleh, N. Bouganim, J. Hilton, A. Arnaout, M. Clemons
 
Vol 19, No 3 (2012) Neoadjuvant erlotinib and surgical resection of a stage IIIA papillary adenocarcinoma of the lung with an L861Q activating EGFR mutation Abstract   PDF   HTML
M. Ong, K. Kwan, S. Kamel-Reid, M. David Vincent
 
Vol 24, No 5 (2017) Neoadjuvant systemic therapy in breast cancer: use and trends in radiotherapy practice Abstract   PDF   HTML
T.A. Koulis, K. Beecham, C. Speers, S. Tyldesley, D. Voduc, C. Simmons, R. Olson
 
Vol 25, No 2 (2018) Neutrophil–lymphocyte ratio predicts response to chemotherapy in triple-negative breast cancer Abstract   PDF   HTML
S. Chae, K.M. Kang, H.J. Kim, E. Kang, S.Y. Park, J.H. Kim, S.H. Kim, S.W. Kim, E.K. Kim
 
Vol 20, No 2 (2013) New chart review data validates administrative data- based indicator for guideline-recommended treatment of locally advanced non-small cell lung cancer and shed light on reasons for non-referral and non-treatment Abstract   PDF   HTML
J. Klein–Geltink, T. Forte, R. Rahal, G. Darling, W. Cheung, R. Alvi, G. Noonan, C. Russell, K. Vriends, J. Niu, G. Lockwood, H. Bryant
 
Vol 14, No 1 (2007) New Multidisciplinary Prostate Bone Metastases Clinic---First of its Kind in Canada Abstract   PDF
Philiz Goh, Kristin Harris, Julie Napolskikh, Edward Chow, Emily Sinclair, Urban Emmenegger, Sharon Lemon, Albert Yee, Lesia Wynnychuk, Jeff Myers, Cyril Danjoux, Yoo-Joung Ko
 
Vol 24, No 6 (2017) No evidence of excessive cancer screening in female noncarriers from BRCA1/2 mutation–positive families Abstract   PDF   HTML
S. Guedaoura, S. Pelletier, W.D. Foulkes, P. Hamet, J. Simard, N. Wong, Z. El Haffaf, J. Chiquette, M. Dorval
 
Vol 16, No 4 (2009) Non-adenomatous non-epithelial carcinoma (hemangiopericytoma) of prostate treated with conservative surgery followed by adjuvant chemoradiation Details   PDF
Bikramjit Chakrabarti, Sajal Kumar Ghosh, Suman Ghorai, Bishan Basu, Phalguni Gupta, Suparna Ghosh Ray, Chaitparna Das
 
Vol 21, No 3 (2014) Non-myeloablative allogeneic hematopoietic transplantation for patients with hematologic malignancies: 9-year single-centre experience Abstract   PDF   HTML
N.I. AlJohani, K. Thompson, W. Hasegawa, D. White, A. Kew, S. Couban
 
Vol 22, No 4 (2015) Nonsurgical treatment of recurrent glioblastoma Abstract   PDF   HTML
O. Gallego
 
Vol 22, No 1 (2015) Novel agents and associated toxicities of inhibitors of the pi3k/Akt/mtor pathway for the treatment of breast cancer Abstract   PDF   HTML
S. Chia, S. Gandhi, A.A. Joy, S. Edwards, M. Gorr, S. Hopkins, J. Kondejewski, J.P. Ayoub, N. Califaretti, D. Rayson, S. Dent
 
Vol 16, No 3 (2009) Novel developments in angiogenesis cancer therapy Details   PDF
Hal W Hirte
 
Vol 20, No 4 (2013) Nutrition and exercise interventions for patients with lung cancer appear beneficial, but more studies are required Abstract   PDF   HTML
N. Kiss, E. Isenring
 
Vol 18, No 3 (2011) O. Harold Warwick: Canada’s first medical oncologist Abstract   PDF   HTML
D. H. Cowan
 
Vol 19, No 4 (2012) Occult cause of paraneoplastic acanthosis nigricans in a patient with known breast dcis: case and review Abstract   PDF   HTML
B. D. Jakubovic, H. F. Sawires, D. N. Adam
 
Vol 20, No 5 (2013) Oncofertility in Canada: an overview of Canadian practice and suggested action plan Abstract   PDF   HTML
R. Ronn, H.E.G. Holzer
 
Vol 21, No 1 (2014) Oncofertility in Canada: cryopreservation and alternative options for future parenthood Abstract   PDF   HTML
R. Ronn, H.E.G. Holzer
 
Vol 20, No 6 (2013) Oncofertility in Canada: gonadal protection and fertility-sparing strategies Abstract   PDF   HTML
R. Ronn, H.E.G. Holzer
 
Vol 20, No 4 (2013) Oncofertility in Canada: the impact of cancer on fertility Abstract   PDF   HTML
R. Ronn, H.E.G. Holzer
 
Vol 22, No 6 (2015) Oncologist heal thyself: hallmarks of happiness Abstract   PDF   HTML
C. Jacobs, M. Clemons, A.A. Joy
 
Vol 21, No 1 (2014) Oncology education in Canadian undergraduate and postgraduate medical programs: a survey of educators and learners Abstract   PDF   HTML
V.C. Tam, S. Berry, T. Hsu, S. North, A. Neville, K. Chan, S. Verma
 
Vol 22, No 3 (2015) Ondansetron rapidly dissolving film for the prophylactic treatment of radiation-induced nausea and vomiting—a pilot study Abstract   PDF   HTML
E. Wong, N. Pulenzas, G. Bedard, C. DeAngelis, L. Zhang, M. Tsao, C. Danjoux, N. Thavarajah, B. Lechner, R. McDonald, P.M. Cheon, E. Chow
 
Vol 21, No 3 (2014) One compared with two cycles of mitomycin C in chemoradiotherapy for anal cancer: analysis of outcomes and toxicity Abstract   PDF   HTML
R. Yeung, Y. McConnell, G. Roxin, R. Banerjee, G.B. Roldán Urgoiti, A.R. MacLean, W.D. Buie, K.E. Mulder, M.M. Vickers, K.J. Joseph, C.M. Doll
 
Vol 17, No 2 (2010) One year of complete clinical response in a metastatic breast cancer patient treated with a combination of lapatinib and gemcitabine Abstract   PDF
J. M. Gasent Blesa, J. B. Laforga Canales, V. Alberola Candel
 
Vol 20, No 3 (2013) Opportunistic salpingectomy: the way forward—response to Steven Narod Abstract   PDF   HTML
D.M. Miller, J.N. McAlpine, C.B. Gilks, D.G. Huntsman
 
Vol 14, No 5 (2007) Optimal Chemotherapy Treatment for Women with Recurrent Ovarian Cancer Details   PDF
Michael Fung-Kee-Fung, Thomas Oliver, Laurie Elit, Holger W Hirte, Peter Bryson
 
Vol 19, No 4 (2012) Optimal prophylactic and definitive therapy for bicalutamide-induced gynecomastia: results of a meta-analysis Abstract   PDF   HTML
M. A. Tunio, M. Al-Asiri, A. Al-Amro, Y. Bayoumi, M. Fareed
 
Vol 22 (2015): Updated Guidelines, Consensus and Evidence-Based Reports in Breast Cancer Optimal systemic therapy for early breast cancer in women: a clinical practice guideline Abstract   PDF   HTML
A. Eisen, G.G. Fletcher, S. Gandhi, M. Mates, O.C. Freedman, S.F. Dent, M.E. Trudeau, members of the Early Breast Cancer Systemic Therapy Consensus Panel
 
Vol 16, No 3 (2009) Optimal use of taxanes in metastatic breast cancer Abstract   PDF
Karen M King, Sasha Lupichuk, Lubna Baig, Marc Webster, Sanraj Basi, Darlene Whyte, Serena Rix
 
Vol 21, No 5 (2014) Optimism about breakthroughs in the age of targeted therapy: the Canadian Lung Cancer Conference 2014; Vancouver, British Columbia; February 7, 2014 Abstract   PDF   HTML
B. Melosky, C. Ho
 
Vol 21, No 1 (2014) Optimizing outcomes with azacitidine: recommendations from Canadian centres of excellence Abstract   PDF   HTML
R.A. Wells, B. Leber, N.Y. Zhu, J.M. Storring
 
Vol 16, No 4 (2009) Optimizing the management of advanced non-small-cell lung cancer: a personal view Abstract   PDF
Mark D. Vincent
 
Vol 17, No 4 (2010) Optimizing the management of HER2-positive early breast cancer: the clinical reality Abstract   PDF
Su. Verma, S. Lavasani, J. Mackey, K. Pritchard, M. Clemons, S. Dent, J. Latreille, J. Lemieux, L. Provencher, Sh. Verma, S. Chia, B. Wang, D. Rayson
 
Vol 24, No 4 (2017) Oral Chinese herbal medicine as maintenance treatment after chemotherapy for advanced non-small-cell lung cancer: a systematic review and meta-analysis Abstract   PDF   HTML
Q. Wang, Q. Wang, S.F. Wang, L.J. Jiao, R.X. Zhang, Y. Zhong, J. Zhang, L. Xu
 
Vol 24, No 6 (2017) Orbital mass as first presentation of metastatic p16-positive oropharyngeal squamous cell carcinoma Abstract   PDF   HTML
J. Corbett, D. Wilke, J. Trites, N. Lamond
 
Vol 23 (2016): Original Cancer Costing Research Using Canadian Data Original Canadian cancer costing research for cancer control sustainability, quality, and value Abstract   PDF   HTML
H. Bryant
 
Vol 21, No 3 (2014) Ottawa Cardiac Oncology Program wins 2013 Cancer Quality Council of Ontario Innovation Award Abstract   PDF   HTML
J. Sulpher, C. Johnson, M. Turek, A. Law, E. Stadnick, S. Hopkins, N. Graham, S.F. Dent
 
Vol 22 (2015): Updated Guidelines, Consensus and Evidence-Based Reports in Breast Cancer Outcome of patients with pregnancy during or after breast cancer: a review of the recent literature Abstract   PDF   HTML
J. Raphael, M.E. Trudeau, K. Chan
 
Vol 19, No 4 (2012) Outcomes of accelerated hypofractionated radiotherapy in stage I non-small-cell lung cancer Abstract   PDF   HTML
T. Yung, M. E. Giuliani, L. W. Le, A. Sun, B.C.J. Cho, A. Bezjak, A. Brade, A. J. Hope
 
Vol 20, No 6 (2013) Outcomes of her2-positive early-stage breast cancer in the trastuzumab era: a population-based study of Canadian patients Abstract   PDF   HTML
U. Zurawska, D.A. Baribeau, S. Giilck, C. Victor, S. Gandhi, A. Florescu, S. Verma
 
Vol 19, No 3 (2012) Outcomes of surveillance for contralateral breast cancer in patients less than age 60 at the time of initial diagnosis Abstract   PDF   HTML
C. Weinstock, R. Bigenwald, T. Hochman, P. Sun, S.A. Narod, E. Warner
 
Vol 19, No 4 (2012) Outcomes of women with early-stage breast cancer receiving adjuvant trastuzumab Abstract   PDF   HTML
M. D. Seal, C. H. Speers, S. O'Reilly, K. A. Gelmon, S. L. Ellard, S. K. Chia
 
Vol 24, No 2 (2017) Ovarian cancer in Manitoba: trends in incidence and survival, 1992–2011 Abstract   PDF   HTML
P. Lambert, K. Galloway, A. Altman, M.W. Nachtigal, D. Turner
 
Vol 24, No 6 (2017) Ovarian function after chemotherapy in young breast cancer survivors Abstract   PDF   HTML
K. Morarji, O. McArdle, K. Hui, G. Gingras-Hill, S. Ahmed, E.M. Greenblatt, E. Warner, S. Sridhar, A.M.F. Ali, A. Azad, D.C. Hodgson
 
Vol 20, No 2 (2013) Overall survival should be the primary endpoint in clinical trials for advanced non-small cell lung cancer Abstract   PDF   HTML
P.K. Cheema, R.L. Burkes
 
Vol 25 (2018): Advances in Breast and Lung Cancers for the Community Oncologist Overcoming endocrine resistance in hormone receptor–positive breast cancer Abstract   PDF   HTML
A. AlFakeeh, C. Brezden-Masley
 
Vol 22, No 1 (2015) Overdiagnosis in breast cancer chemoprevention trials Abstract   PDF   HTML
V. Sopik, S.A. Narod
 
Vol 25, No 2 (2018) Overwhelming research and clinical evidence of exercise medicine efficacy in cancer management—translation into practice is the challenge before us Abstract   PDF   HTML
R.U. Newton
 
Vol 18, No 1 (2011) Oxaliplatin: a review in the era of molecularly targeted therapy Abstract   PDF   HTML
T. Alcindor, N. Beauger
 
Vol 19 (2012): Oncology in China Oxidative DNA damage of lymphocytes in peripheral blood and ascites in cancer patients Abstract   PDF   HTML
J. Wang, S. S. Xing, S. B. Guo, W. Jin, W. Zhang
 
Vol 20, No 4 (2013) Pain assessment during conscious sedation for cervical cancer high-dose-rate brachytherapy Abstract   PDF   HTML
H. Bhanabhai, R. Samant, C. E, L. Grenier, S. Lowry
 
Vol 23, No 5 (2016) Painless neutropenic enterocolitis in a patient undergoing chemotherapy Abstract   PDF   HTML
E.J. Chow, K.D. Bishop
 
Vol 24, No 3 (2017) Palliative care as a public health issue: understanding disparities in access to palliative care for the homeless population living in Toronto, based on a policy analysis Abstract   PDF   HTML
B. Henry, N. Dosani, L. Huynh, N. Amirault
 
Vol 22, No 5 (2015) Palliative chemotherapy for patients 70 years of age and older with metastatic colorectal cancer: a single-centre experience Abstract   PDF   HTML
D. Bossé, M. Vickers, F. Lemay, A. Beaudoin
 
Vol 23, No 3 (2016) Palliative chemotherapy in advanced colorectal cancer patients 80 years of age and older Abstract   PDF   HTML
P. Lai, S. Sud, T. Zhang, T. Asmis, P. Wheatley-Price
 
Vol 21, No 2 (2014) Palliative sedation— still a complex clinical issue! Abstract   PDF   HTML
R.L. Fainsinger
 
Vol 18, No 3 (2011) Pan-Canadian initiatives in colorectal cancer screening: adopting knowledge translation tools to accelerate uptake and impact Abstract   PDF   HTML
H. E. Bryant, S. V. Fekete, D. H. Major
 
2008: Presentations from the Integrating Wellness into Cancer Care Conference Panel Discussion 1 Abstract   PPT Presentation
S Sutcliffe, G. Deng, L. Wright, J. Maher, S. Sagar
 
2008: Presentations from the Integrating Wellness into Cancer Care Conference Panel Discussion 2 Abstract   PPT Presentation
M. Philp, G. Payne, A. Cunningham, M. Vachon
 
2008: Presentations from the Integrating Wellness into Cancer Care Conference Panel Discussion 3 Abstract   PPT Presentation
B. Bell, Terry Sullivan, M. Vachon, P. Catton, A. Jadad, L. Morrison
 
Vol 20, No 6 (2013) Panitumumab monotherapy compared with cetuximab and irinotecan combination therapy in patients with previously treated KRAS wild-type metastatic colorectal cancer Abstract   PDF   HTML
H. Kennecke, L. Chen, C.D. Blanke, W.Y. Cheung, K. Schaff, C. Speers
 
Vol 24, No 5 (2017) Papillary thyroid carcinoma in a boy with familial tuberous sclerosis complex attributable to a TSC2 deletion—a case report Abstract   PDF   HTML
M. Flader, P. Kurzawa, J. Maldyk, J. Sygut, J. Harasymczuk, A. Kropinska, D. Handkiewicz-Junak, B. Jarzab, K. Kotulska, M. Niedziela
 
Vol 22, No 6 (2015) Para-aortic and pelvic extended-field radiotherapy for advanced-stage uterine cancer: dosimetric and toxicity comparison between the four-field box and intensity-modulated techniques Abstract   PDF   HTML
A. Rabinovich, L. Bernard, A.V. Ramanakumar, G. Stroian, W.H. Gotlieb, S. Lau, B. Bahoric
 
Vol 16, No 6 (2009) Partial cancerous changes eventually developing into superficial spreading cancer over 18 months Abstract   PDF
Y. Song, Z. Wang, Q. Tang, H. Xu, C. Xing, Z. Miao, C. Yang
 
Vol 17, No 1 (2010) Pathology re-review as an essential component of breast cancer management Abstract   PDF
C.G. Kleer
 
Vol 18 (2011): The Optimization of Hormonal Therapy in Early Breast Cancer Patient adherence to aromatase inhibitor treatment in the adjuvant setting Abstract   PDF   HTML
S. Verma, Y. Madarnas, S. Sehdev, G. Martin, J. Bajcar
 
Vol 15 (2008): Supplement - Integrative Oncology: A Canadian and International Perspective Patient Decision-Making about Complementary and Alternative Medicine (CAM) in Cancer Management: The Context and Process Abstract   PDF
Lynda G Balneaves
 
Vol 21, No 2 (2014) Patient perceptions of a comprehensive cancer navigation service Abstract   PDF   HTML
W. Hryniuk, R. Simpson, A. McGowan, P. Carter
 
801 - 900 of 1444 Items << < 4 5 6 7 8 9 10 11 12 13 > >>